Merrimack Pharmaceuticals, Inc. (MACK)
NASDAQ: MACK · IEX Real-Time Price · USD
14.72
+0.04 (0.27%)
At close: Apr 19, 2024, 4:00 PM
14.68
-0.04 (-0.27%)
After-hours: Apr 19, 2024, 7:03 PM EDT

Merrimack Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2008
Revenue
000000000102.76
Upgrade
Revenue Growth (YoY)
---------115.03%
Upgrade
Gross Profit
000000000102.76
Upgrade
Selling, General & Admin
2.182.172.625.0116.1715.628.4532.0524.0530.52
Upgrade
Research & Development
000011.149.9767.31109.57121.03138.5
Upgrade
Other Operating Expenses
-0.14-0.45-0.14-2.14-4.91005.7100
Upgrade
Operating Expenses
2.041.732.472.8722.3665.5895.77147.33145.08169.01
Upgrade
Operating Income
-2.04-1.73-2.47-2.87-22.36-65.58-95.77-147.33-145.08-66.26
Upgrade
Interest Expense / Income
00001.530.9634.6522.4518.7718.23
Upgrade
Other Expense / Income
-0.87-0.19-0.020.14-5.08-18.33-560.05-4.81-4.68-1.2
Upgrade
Pretax Income
-1.17-1.54-2.45-3.01-18.81-48.2429.63-164.96-159.17-83.29
Upgrade
Income Tax
0.01000.01-1.47-7.7-42.4-13.22-11.220
Upgrade
Net Income
-1.18-1.54-2.46-3.03-17.33-40.51472.03-151.74-147.96-83.29
Upgrade
Shares Outstanding (Basic)
14141313131313131110
Upgrade
Shares Outstanding (Diluted)
14141313131313131110
Upgrade
Shares Change
5.73%0.87%0.20%0.20%0.07%0.84%5.58%12.54%6.66%5.55%
Upgrade
EPS (Basic)
-0.08-0.11-0.18-0.23-1.30-3.0335.67-12.11-13.29-8.00
Upgrade
EPS (Diluted)
-0.08-0.11-0.18-0.23-1.30-3.0335.67-12.11-13.29-8.00
Upgrade
Free Cash Flow
-1.52-1.74-0.22-4.63-29.34-65.63-125.63-172.88-117.26-40.84
Upgrade
Free Cash Flow Per Share
-0.11-0.13-0.02-0.35-2.20-4.92-9.49-13.79-10.53-3.91
Upgrade
Dividend Per Share
----1.997-10.552---
Upgrade
Gross Margin
---------100.00%
Upgrade
Operating Margin
----------64.48%
Upgrade
Profit Margin
----------81.06%
Upgrade
Free Cash Flow Margin
----------39.75%
Upgrade
Effective Tax Rate
-------9.87%---
Upgrade
EBITDA
-1.17-1.54-2.45-3.01-15.05-43.17469.5-137.62-137.15-61.84
Upgrade
EBITDA Margin
----------60.18%
Upgrade
Depreciation & Amortization
00002.234.075.224.93.253.22
Upgrade
EBIT
-1.17-1.54-2.45-3.01-17.28-47.25464.28-142.52-140.4-65.06
Upgrade
EBIT Margin
----------63.32%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).